Stay updated on VX-152 Combo Safety in CF Adults Clinical Trial
Sign up to get notified when there's something new on the VX-152 Combo Safety in CF Adults Clinical Trial page.

Latest updates to the VX-152 Combo Safety in CF Adults Clinical Trial page
- Check6 days agoChange DetectedThe web page has been updated to version 2.16.0, replacing the previous version 2.15.2.SummaryDifference0.3%
- Check13 days agoNo Change Detected
- Check20 days agoNo Change Detected
- Check28 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2.SummaryDifference0.1%
- Check42 days agoChange DetectedThe page has undergone significant changes, including the removal of detailed study information regarding VX-152 for cystic fibrosis, while retaining the drug name and revision number.SummaryDifference21%
- Check49 days agoChange DetectedThe web page has been updated from version 2.14.3 to version 2.14.4.SummaryDifference0.1%
- Check57 days agoChange DetectedThe web page has been updated from version 2.14.2 to version 2.14.3.SummaryDifference0.1%
- Check93 days agoChange DetectedThe page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.SummaryDifference1%
Stay in the know with updates to VX-152 Combo Safety in CF Adults Clinical Trial
Enter your email address, and we'll notify you when there's something new on the VX-152 Combo Safety in CF Adults Clinical Trial page.